Announces the publication of a new open-access quarterly report: AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview 2019/Q1. Except for providing the analysis of 350 investors, 50 corporations and 150 companies operating in the field, the main events that took place in the industry from January to March 2019 are covered. The report also features the list of 30 leading R&D centers that provide important researches in the segment.
Link to the Report: https://www.ai-pharma.dka.global/quarter-1-2019
#AI #artificialintelligence #drugdiscovery
Read more
Comments are closed.